Yasho Industries Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/43qoupvskfnvrkq1hnql79db.pdf

Key Takeaways


Pakhajan Ramp-Up: The Core Execution Story

Parag Jhaveri: "Pakhajan is not fully monetized. It will take at least to monetize the full assets of Pakhajan, we will need 3 years minimum 3 to 4 years purely because we have spent about INR250 crores on peripheral infrastructure creation."

Revenue Mix & Demand Dynamics

Parag Jhaveri: "No, it will be onetime. We don't expect that to grow this. This is purely that our sales into the industrial segment were a little subdued due to the demand and also the year-end for a lot of customers, MNC is being a December month we were not able to push the sales."

Balance Sheet & Fundraise


US Subsidiary & Geographic Expansion


Tariff Risk: Assumption, Not a Plan

Parag Jhaveri: "We are not anticipating that there will be a higher tariff on the Indian product getting into U.S.A. That's we are quite a bit uncertain. If there will be any tariff, it will be across the board, not only on product originate from India as of today, what we have a conversation with our friends."

Guidance & Commitments

CommitmentSpecificsTimeline
Pakhajan utilizationCross 50% capacityMarch 2025 onwards
Q4 blended utilization35% to 40%Q4 FY25
Q4 volume growthAggregate growth of ~30% to 35%By end of FY25
FY25 total revenueINR650 crores to INR670 croresFY25
Inventory normalizationReturn to normal levelsBy March 2025
FY26 revenueINR950 crores to INR1,000 croresFY26
FY26 EBITDA margin17% to 19% minimumFY26
FY26 exit utilization (Pakhajan)85% to 90%Last quarter of FY26
FY27 revenueINR1,250 crores to INR1,300 crores, assuming both plants run full from day 1FY27
FY27 EBITDA margin18% plus/minus oneFY27
Debt-to-EBITDAClose to 3.5xBy FY26
New product capexTriggered once Pakhajan utilization surpasses 70%FY26
Full Pakhajan asset monetizationMinimum 3 to 4 years from nowFY28–FY29

Key Metrics

MetricQ3 FY25
Revenue from operations₹148 cr, +14.7% YoY, driven by 8% volume growth
Export share of revenue66% of total revenue
EBITDA₹27 cr, EBITDA margin of 18.4%
Gross margin38% to 39% is a sustainable level
Industrial chemicals revenue share79% of total revenue, vs 87% in Q3 FY24
Consumer chemicals revenue share21% of total revenue
9M FY25 revenue from operations₹486 cr, +15% YoY
9M FY25 EBITDA₹83 cr, EBITDA margin of 16.8%
9M FY25 PAT₹1 cr, impacted by higher depreciation and finance costs from new plant
FY25 revenue guidance₹650 cr to ₹670 cr
FY26 revenue guidance₹950 cr to ₹1,000 cr, EBITDA margin 17% to 19%
FY27 revenue guidance₹1,250 cr to ₹1,300 cr, EBITDA margin 18% plus/minus 1%
Pakhajan capacity utilization (December)Close to 30%
Pakhajan utilization guidance (Q4 FY25 blended)35% to 40%
Pakhajan utilization guidance (exit Q4 FY26)85% to 90%
Fundraise via preferential allotment₹125 cr, ₹50 cr for debt repayment, ₹75 cr retained for working capital and future capex
Current cost of debt8.6% to 8.8%
Debt to EBITDA target by FY26Close to 3.5x
Q4 FY25 volume growth guidance30% to 35% aggregate growth by year-end
Inventory level₹100 cr to ₹160 cr, elevated due to orders on hold, expected to normalize by March
Peak utilization EBITDA capacity (both plants)Roughly ₹220 cr to ₹240 cr (per an analyst's math)